Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Mucositis × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Melanoma 2 Glioblastoma 2 Brain Neoplasms 2 Advanced Solid Tumor 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Ulnar Neuropathies 1 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Prostatic Hyperplasia 1 Peripheral Lung Tumor 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Squamous Lung Cancer 1 Neuroma 1 Multiple Myeloma 1 Mucositis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hyperthermia 1 Glioma 1

Interventions

Radiotherapy 4 angiotensin I (1-7) 3 Injections 3 Cisplatin 3 RRx-001 2 tempol 1 hydrated silica gel-based toothpaste 1 brilacidin 1 apraglutide 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Water 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Lidocaine 1 Fibroblast Growth Factor 7 1 Drug Therapy 1 Diphenhydramine 1 Betaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04046250 2023-08-25

TK112690

Tosk, Inc.

Phase 2 Completed

22 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡